Amgen cold sore virus drug shows ‘significant’ cancer benefit
May 27, 2015Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec
Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …
Eisai epilepsy drug sees EMA nod
May 27, 2015Research and Development, Sales and Marketing Eisai, Fycompa, ema. epilepsy
Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …
Sanofi appoints external affairs VP
May 27, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, suresh kumar
Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice …
PrimeVigilance and Sound Opinion join forces
May 26, 2015acquisition, medical information, primevigilance
Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …
Sanofi prostate cancer drug to remain on CDF
May 26, 2015Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate
Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …
Otsuka, ViiV and AstraZeneca named in ABPI code complaints
May 26, 2015Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Otsuka, PMCPA, ViiV
A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …
Amgen pulls out of psoriasis deal with AstraZeneca
May 26, 2015Sales and Marketing Amgen, AstraZeneca, psoriasis
Amgen has ended its agreement with AstraZeneca to develop a new biologic for psoriasis, because of the likelihood of ‘restrictive …
Medicago invests big into plant-based vaccines
May 26, 2015Manufacturing and Production, Sales and Marketing Canada, Quebec, medicago, vaccines
Canadian biotech Medicago is building a $245 million new production complex in Quebec to make more vaccines and therapeutics based …
GSK head joins Nabriva as chief medical officer
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elyse Seltzer, GSK, Nabriva Therapeutics
Austrian-based clinical stage biopharma firm Nabriva Therapeutics has appointed Dr Elyse Seltzer as its chief medical officer. Seltzer assumes the role …
After the UK general election, what’s next for pharma?
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, election, medcity
In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …
EMA recommends eight drugs for approval
May 22, 2015Sales and Marketing Amgen, BMS, EMA, Janssen, Merck, keytruda
The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha …
Bayer wins Cancer Drugs Fund appeal
May 22, 2015Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly
Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …
Sanofi’s rheumatoid arthritis biologic performs
May 22, 2015Sales and Marketing Sanofi, rheumatoid arthritis, sarilumab
French pharma giant Sanofi plans to submit its new rheumatoid arthritis biologic for regulatory approval in the US after it …
Boehringer and Eureka reach cancer antibodies deal
May 22, 2015Research and Development, Sales and Marketing Boehringer, eureka
Boehringer Ingelheim and Eureka Therapeutics have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology.No …
GW Pharma appoints president and moves CEO to US
May 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GW Pharmaceuticals, Julian Gangolli
US biopharma firm GW Pharmaceuticals has appointed Julian Gangolli as president of its North American division, and is also relocating its …
Analysts predict Pfizer to swallow GSK
May 21, 2015Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger
GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …
Pharma firm seeks judicial review against transparency
May 21, 2015Medical Communications, Research and Development, Sales and Marketing Richmond Pharmacology, hra, transparency
The battle for greater transparency in the pharma industry is to take another twist after a company lodged a legal …
J&J to file 10 new key drugs by 2019
May 21, 2015Sales and Marketing J&J, JJ
Johnson & Johnson says it plans to file 10 new products with regulators between 2015 and 2019 with each having …
Pfizer board member stepping down
May 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marc Tessier-Lavigne, Pfizer
Dr Marc Tessier-Lavigne is leaving Pfizer’s board of directors to work on the launch of Denali, a new biotech company …
Industry awaits key immunotherapy results at ASCO
May 20, 2015Research and Development, Sales and Marketing ASCO, Cancer, oncology, pharma
This year’s American Society of Clinical Oncology (ASCO) conference has a strong focus on immunotherapy, as pharma ramps up its …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
